Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Monday, July 24, 2017

Just a Few Vaccine Refusers Could Endanger Many stat : WebMD

"Measles is really the canary in the coal mine," noted Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia. "The meaning is that even small declines in vaccine coverage in children owing to vaccine hesitancy may have substantial public health and economic consequences that will be larger when considering unvaccinated infants, adolescents and adults," explained study author Nathan Lo. He conducted the research with senior study author Dr. Peter Hotez, dean of Baylor's National School of Tropical Medicine, in Houston. The study authors pointed out that -- barring a medical (or other) exemption -- all 50 states require that all children get the MMR vaccine, alongside a full complement of childhood vaccines, before enrolling in day care or elementary school. Even without face-to-face contact, the virus is capable of remaining airborne and infectious in any given space for upwards of two hours.



Just a Few Vaccine Refusers Could Endanger Many
Trials to test a vaccine to prevent the development of Type-1 diabetes may start as early as next year. The research is based on the idea that a group of viruses, known as enteroviruses, are thought to play a role in the development of Type-1 diabetes. The next round of trials will assess whether or not the vaccine is safe in 30 adult humans. The vaccine has so far been tested successfully in mice, with the first phase of human trials expected to begin in Finland in late 2018. "Additionally, the vaccine would protect from infections caused by enteroviruses such as the common cold, myocarditis, meningitis, and ear infections.

Diabetes Vaccine Entering Human Testing Could Also Prevent the Common Cold


Vaccine To Prevent Type-1 Diabetes Could Be Trialed In Humans As Early As Next Year
After years of preliminary studies, researchers at the University of Tampere, in Finland, are finally ready to test their diabetes vaccine in clinical trials. With that information in hand, they set out to create a prototype vaccine. "The aim is to develop a vaccine that could prevent a significant number of type 1 diabetes cases. Enteroviruses are RNA-based viruses linked to many human ailments, including polio; the common cold; hand, foot and mouth disease; and several others. Additionally, the vaccine would protect from infections caused by enteroviruses such as the common cold, myocarditis, meningitis and ear infections.


collected by :Lucy William

To follow all the new news about Health care

No comments:

Post a Comment